DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics

Abstract

We report structural analysis of HIV protease variant PRS17 which was rationally selected by machine learning to represent wide classes of highly drug-resistant variants. Crystal structures were solved of PRS17 in the inhibitor-free form and in complex with antiviral inhibitor, darunavir. Despite its 17 mutations, PRS17 has only one mutation (V82S) in the inhibitor/substrate binding cavity, yet exhibits high resistance to all clinical inhibitors. PRS17 has none of the major mutations (I47V, I50V, I54ML, L76V and I84V) associated with darunavir resistance, but has 10,000-fold weaker binding affinity relative to the wild type PR. Comparable binding affinity of 8000-fold weaker than PR is seen for drug resistant mutant PR20, which bears 3 mutations associated with major resistance to darunavir (I47V, I54L and I84V). Inhibitor-free PRS17 shows an open flap conformation with a curled tip correlating with G48V flap mutation. NMR studies on inactive PRS17 D25N unambiguously confirm that the flaps adopt mainly an open conformation in solution very similar to that in the inhibitor-free crystal structure. In PRS17, the hinge loop cluster of mutations, E35D, M36I and S37D, contributes to the altered flap dynamics by a mechanism similar to that of PR20. An additional K20R mutation anchors an altered conformation ofmore » the hinge loop. Flap mutations M46L and G48V in PRS17/DRV complex alter the Phe53 conformation by steric hindrance between the side chains. Unlike the L10F mutation in PR20, L10I in PRS17 does not break the inter-subunit ion pair or diminish the dimer stability, consistent with a very low dimer dissociation constant comparable to that of wild type PR. Distal mutations A71V, L90M and I93L propagate alterations to the catalytic site of PRS17. PRS17 exhibits a molecular mechanism whereby mutations act synergistically to alter the flap dynamics resulting in significantly weaker binding yet maintaining active site contacts with darunavir.« less

Authors:
 [1];  [2];  [3];  [1]; ORCiD logo [1];  [4]
  1. Georgia State Univ., Atlanta, GA (United States)
  2. National Inst. of Health (NIH), Bethesda, MD (United States)
  3. National Inst. of Health (NIH), Bethesda, MD (United States); Iowa State Univ., Ames, IA (United States)
  4. Univ. of Pittsburgh, PA (United States)
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES); National Institutes of Health (NIH)
OSTI Identifier:
1337185
Grant/Contract Number:  
W-31-109-Eng-38; GM062920
Resource Type:
Accepted Manuscript
Journal Name:
PLoS ONE
Additional Journal Information:
Journal Volume: 11; Journal Issue: 12; Journal ID: ISSN 1932-6203
Publisher:
Public Library of Science
Country of Publication:
United States
Language:
ENGLISH
Subject:
59 BASIC BIOLOGICAL SCIENCES; crystal structure; proteases; antimicrobial resistance; dimers (chemical physics); hydrogen bonding; HIV; crystallization; NMR spectroscopy

Citation Formats

Agniswamy, Johnson, Louis, John M., Roche, Julien, Harrison, Robert W., Weber, Irene T., and Sluis-Cremer, Nicolas. Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics. United States: N. p., 2016. Web. doi:10.1371/journal.pone.0168616.
Agniswamy, Johnson, Louis, John M., Roche, Julien, Harrison, Robert W., Weber, Irene T., & Sluis-Cremer, Nicolas. Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics. United States. https://doi.org/10.1371/journal.pone.0168616
Agniswamy, Johnson, Louis, John M., Roche, Julien, Harrison, Robert W., Weber, Irene T., and Sluis-Cremer, Nicolas. Fri . "Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics". United States. https://doi.org/10.1371/journal.pone.0168616. https://www.osti.gov/servlets/purl/1337185.
@article{osti_1337185,
title = {Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics},
author = {Agniswamy, Johnson and Louis, John M. and Roche, Julien and Harrison, Robert W. and Weber, Irene T. and Sluis-Cremer, Nicolas},
abstractNote = {We report structural analysis of HIV protease variant PRS17 which was rationally selected by machine learning to represent wide classes of highly drug-resistant variants. Crystal structures were solved of PRS17 in the inhibitor-free form and in complex with antiviral inhibitor, darunavir. Despite its 17 mutations, PRS17 has only one mutation (V82S) in the inhibitor/substrate binding cavity, yet exhibits high resistance to all clinical inhibitors. PRS17 has none of the major mutations (I47V, I50V, I54ML, L76V and I84V) associated with darunavir resistance, but has 10,000-fold weaker binding affinity relative to the wild type PR. Comparable binding affinity of 8000-fold weaker than PR is seen for drug resistant mutant PR20, which bears 3 mutations associated with major resistance to darunavir (I47V, I54L and I84V). Inhibitor-free PRS17 shows an open flap conformation with a curled tip correlating with G48V flap mutation. NMR studies on inactive PRS17 D25N unambiguously confirm that the flaps adopt mainly an open conformation in solution very similar to that in the inhibitor-free crystal structure. In PRS17, the hinge loop cluster of mutations, E35D, M36I and S37D, contributes to the altered flap dynamics by a mechanism similar to that of PR20. An additional K20R mutation anchors an altered conformation of the hinge loop. Flap mutations M46L and G48V in PRS17/DRV complex alter the Phe53 conformation by steric hindrance between the side chains. Unlike the L10F mutation in PR20, L10I in PRS17 does not break the inter-subunit ion pair or diminish the dimer stability, consistent with a very low dimer dissociation constant comparable to that of wild type PR. Distal mutations A71V, L90M and I93L propagate alterations to the catalytic site of PRS17. PRS17 exhibits a molecular mechanism whereby mutations act synergistically to alter the flap dynamics resulting in significantly weaker binding yet maintaining active site contacts with darunavir.},
doi = {10.1371/journal.pone.0168616},
journal = {PLoS ONE},
number = 12,
volume = 11,
place = {United States},
year = {Fri Dec 16 00:00:00 EST 2016},
month = {Fri Dec 16 00:00:00 EST 2016}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 30 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance
journal, February 2016


Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance
journal, February 2016


Modulation of Human Immunodeficiency Virus Type 1 Protease Autoprocessing by Charge Properties of Surface Residue 69
journal, May 2009

  • Huang, Liangqun; Sayer, Jane M.; Swinford, Marie
  • Journal of Virology, Vol. 83, Issue 15
  • DOI: 10.1128/JVI.00473-09

Insights into amprenavir resistance in E35D HIV-1 protease mutation from molecular dynamics and binding free-energy calculations
journal, June 2006

  • Meiselbach, Heike; Horn, Anselm H. C.; Harrer, Thomas
  • Journal of Molecular Modeling, Vol. 13, Issue 2
  • DOI: 10.1007/s00894-006-0121-3

Refinement of Macromolecular Structures by the Maximum-Likelihood Method
journal, May 1997

  • Murshudov, G. N.; Vagin, A. A.; Dodson, E. J.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 53, Issue 3
  • DOI: 10.1107/S0907444996012255

Mutational and Structural Studies Aimed at Characterizing the Monomer of HIV-1 Protease and Its Precursor
journal, April 2007

  • Ishima, Rieko; Torchia, Dennis A.; Louis, John M.
  • Journal of Biological Chemistry, Vol. 282, Issue 23
  • DOI: 10.1074/jbc.m701304200

Highly resistant HIV-1 proteases and strategies for their inhibition
journal, June 2015

  • Weber, Irene T.; Kneller, Daniel W.; Wong-Sam, Andres
  • Future Medicinal Chemistry, Vol. 7, Issue 8
  • DOI: 10.4155/fmc.15.44

Revealing the dimer dissociation and existence of a folded monomer of the mature HIV-2 protease
journal, December 2009

  • Louis, John M.; Ishima, Rieko; Aniana, Annie
  • Protein Science, Vol. 18, Issue 12
  • DOI: 10.1002/pro.261

Structural and kinetic analysis of drug resistant mutants of HIV-1 protease
journal, July 1999


Likelihood-enhanced fast rotation functions
journal, February 2004

  • Storoni, Laurent C.; McCoy, Airlie J.; Read, Randy J.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 3
  • DOI: 10.1107/S0907444903028956

Effect of Flap Mutations on Structure of HIV-1 Protease and Inhibition by Saquinavir and Darunavir
journal, August 2008

  • Liu, Fengling; Kovalevsky, Andrey Y.; Tie, Yunfeng
  • Journal of Molecular Biology, Vol. 381, Issue 1
  • DOI: 10.1016/j.jmb.2008.05.062

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
journal, January 2014


Atomic resolution crystal structures of HIV-1 protease and mutants V82A and I84V with saquinavir
journal, January 2007

  • Tie, Yunfeng; Kovalevsky, Andrey Y.; Boross, Peter
  • Proteins: Structure, Function, and Bioinformatics, Vol. 67, Issue 1
  • DOI: 10.1002/prot.21304

Ultra-high Resolution Crystal Structure of HIV-1 Protease Mutant Reveals Two Binding Sites for Clinical Inhibitor TMC114
journal, October 2006

  • Kovalevsky, Andrey Y.; Liu, Fengling; Leshchenko, Sofiya
  • Journal of Molecular Biology, Vol. 363, Issue 1
  • DOI: 10.1016/j.jmb.2006.08.007

Measurement of 15N relaxation rates in perdeuterated proteins by TROSY-based methods
journal, June 2012


Evolution under Drug Pressure Remodels the Folding Free-Energy Landscape of Mature HIV-1 Protease
journal, July 2016


Binding Kinetics of Darunavir to Human Immunodeficiency Virus Type 1 Protease Explain the Potent Antiviral Activity and High Genetic Barrier
journal, October 2007

  • Dierynck, Inge; De Wit, Mieke; Gustin, Emmanuel
  • Journal of Virology, Vol. 81, Issue 24
  • DOI: 10.1128/JVI.01184-07

Conformational variation of an extreme drug resistant mutant of HIV protease
journal, November 2015

  • Shen, Chen-Hsiang; Chang, Yu-Chung; Agniswamy, Johnson
  • Journal of Molecular Graphics and Modelling, Vol. 62
  • DOI: 10.1016/j.jmgm.2015.09.006

HIV-1 Protease with 20 Mutations Exhibits Extreme Resistance to Clinical Inhibitors through Coordinated Structural Rearrangements
journal, March 2012

  • Agniswamy, Johnson; Shen, Chen-Hsiang; Aniana, Annie
  • Biochemistry, Vol. 51, Issue 13
  • DOI: 10.1021/bi2018317

HIV-1 Protease: Structural Perspectives on Drug Resistance
journal, December 2009

  • Weber, Irene; Agniswamy, Johnson
  • Viruses, Vol. 1, Issue 3
  • DOI: 10.3390/v1031110

Measurement of 15N relaxation rates in perdeuterated proteins by TROSY-based methods
journal, June 2012


Interaction of I50V Mutant and I50L/A71V Double Mutant HIV-Protease with Inhibitor TMC114 (Darunavir): Molecular Dynamics Simulation and Binding Free Energy Studies
journal, February 2012

  • Meher, Biswa Ranjan; Wang, Yixuan
  • The Journal of Physical Chemistry B, Vol. 116, Issue 6
  • DOI: 10.1021/jp2074804

The structural biology of HIV assembly
journal, April 2008

  • Ganser-Pornillos, Barbie K.; Yeager, Mark; Sundquist, Wesley I.
  • Current Opinion in Structural Biology, Vol. 18, Issue 2
  • DOI: 10.1016/j.sbi.2008.02.001

Conformation of Inhibitor-Free HIV-1 Protease Derived from NMR Spectroscopy in a Weakly Oriented Solution
journal, December 2014


Highly resistant HIV-1 proteases and strategies for their inhibition
journal, June 2015

  • Weber, Irene T.; Kneller, Daniel W.; Wong-Sam, Andres
  • Future Medicinal Chemistry, Vol. 7, Issue 8
  • DOI: 10.4155/fmc.15.44

Structural and kinetic analysis of drug resistant mutants of HIV-1 protease
journal, July 1999


Revealing the dimer dissociation and existence of a folded monomer of the mature HIV-2 protease
journal, December 2009

  • Louis, John M.; Ishima, Rieko; Aniana, Annie
  • Protein Science, Vol. 18, Issue 12
  • DOI: 10.1002/pro.261

The HIV Type 1 Protease L10I Minor Mutation Decreases Replication Capacity and Confers Resistance to Protease Inhibitors
journal, January 2011

  • Flor-Parra, Fernando; Pérez-Pulido, Antonio J.; Pachón, Jerónimo
  • AIDS Research and Human Retroviruses, Vol. 27, Issue 1
  • DOI: 10.1089/aid.2010.0072

Likelihood-enhanced fast translation functions
journal, March 2005

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Storoni, Laurent C.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 61, Issue 4
  • DOI: 10.1107/S0907444905001617

Atomic resolution crystal structures of HIV-1 protease and mutants V82A and I84V with saquinavir
journal, January 2007

  • Tie, Yunfeng; Kovalevsky, Andrey Y.; Boross, Peter
  • Proteins: Structure, Function, and Bioinformatics, Vol. 67, Issue 1
  • DOI: 10.1002/prot.21304

Insights into amprenavir resistance in E35D HIV-1 protease mutation from molecular dynamics and binding free-energy calculations
journal, June 2006

  • Meiselbach, Heike; Horn, Anselm H. C.; Harrer, Thomas
  • Journal of Molecular Modeling, Vol. 13, Issue 2
  • DOI: 10.1007/s00894-006-0121-3

Predicting protein functions using incomplete hierarchical labels
journal, January 2015


Improved Cross Validation of a Static Ubiquitin Structure Derived from High Precision Residual Dipolar Couplings Measured in a Drug-Based Liquid Crystalline Phase
journal, February 2014

  • Maltsev, Alexander S.; Grishaev, Alexander; Roche, Julien
  • Journal of the American Chemical Society, Vol. 136, Issue 10
  • DOI: 10.1021/ja4132642

Improved Cross Validation of a Static Ubiquitin Structure Derived from High Precision Residual Dipolar Couplings Measured in a Drug-Based Liquid Crystalline Phase
journal, February 2014

  • Maltsev, Alexander S.; Grishaev, Alexander; Roche, Julien
  • Journal of the American Chemical Society, Vol. 136, Issue 10
  • DOI: 10.1021/ja4132642

Mechanism of Drug Resistance Revealed by the Crystal Structure of the Unliganded HIV-1 Protease with F53L Mutation
journal, May 2006

  • Liu, Fengling; Kovalevsky, Andrey Y.; Louis, John M.
  • Journal of Molecular Biology, Vol. 358, Issue 5
  • DOI: 10.1016/j.jmb.2006.02.076

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
journal, October 2011

  • May, M.; Gompels, M.; Delpech, V.
  • BMJ, Vol. 343, Issue oct11 2
  • DOI: 10.1136/bmj.d6016

Computational Characterization of Structural Role of the Non-active Site Mutation M36I of Human Immunodeficiency Virus Type 1 Protease
journal, July 2007

  • Ode, Hirotaka; Matsuyama, Shou; Hata, Masayuki
  • Journal of Molecular Biology, Vol. 370, Issue 3
  • DOI: 10.1016/j.jmb.2007.04.081

Mechanism of Drug Resistance Revealed by the Crystal Structure of the Unliganded HIV-1 Protease with F53L Mutation
journal, May 2006

  • Liu, Fengling; Kovalevsky, Andrey Y.; Louis, John M.
  • Journal of Molecular Biology, Vol. 358, Issue 5
  • DOI: 10.1016/j.jmb.2006.02.076

Weak alignment NMR: a hawk-eyed view of biomolecular structure
journal, October 2005


Prediction of HIV drug resistance from genotype with encoded three-dimensional protein structure
journal, January 2014


Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Effectiveness of Nonpeptide Clinical Inhibitor TMC-114 on HIV-1 Protease with Highly Drug Resistant Mutations D30N, I50V, and L90M
journal, February 2006

  • Kovalevsky, Andrey Yu.; Tie, Yunfeng; Liu, Fengling
  • Journal of Medicinal Chemistry, Vol. 49, Issue 4
  • DOI: 10.1021/jm050943c

HIV-1 Protease Mutations and Inhibitor Modifications Monitored on a Series of Complexes. Structural Basis for the Effect of the A71V Mutation on the Active Site
journal, September 2006

  • Skálová, Tereza; Dohnálek, Jan; Dušková, Jarmila
  • Journal of Medicinal Chemistry, Vol. 49, Issue 19
  • DOI: 10.1021/jm0605583

Weak alignment NMR: a hawk-eyed view of biomolecular structure
journal, October 2005


Computational Characterization of Structural Role of the Non-active Site Mutation M36I of Human Immunodeficiency Virus Type 1 Protease
journal, July 2007

  • Ode, Hirotaka; Matsuyama, Shou; Hata, Masayuki
  • Journal of Molecular Biology, Vol. 370, Issue 3
  • DOI: 10.1016/j.jmb.2007.04.081

HIV-1 Protease with 20 Mutations Exhibits Extreme Resistance to Clinical Inhibitors through Coordinated Structural Rearrangements
journal, March 2012

  • Agniswamy, Johnson; Shen, Chen-Hsiang; Aniana, Annie
  • Biochemistry, Vol. 51, Issue 13
  • DOI: 10.1021/bi2018317

Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site
journal, April 2004


HIV-1 Protease: Structural Perspectives on Drug Resistance
journal, December 2009

  • Weber, Irene; Agniswamy, Johnson
  • Viruses, Vol. 1, Issue 3
  • DOI: 10.3390/v1031110

NMRPipe: A multidimensional spectral processing system based on UNIX pipes
journal, November 1995

  • Delaglio, Frank; Grzesiek, Stephan; Vuister, GeertenW.
  • Journal of Biomolecular NMR, Vol. 6, Issue 3
  • DOI: 10.1007/BF00197809

Effect of Flap Mutations on Structure of HIV-1 Protease and Inhibition by Saquinavir and Darunavir
journal, August 2008

  • Liu, Fengling; Kovalevsky, Andrey Y.; Tie, Yunfeng
  • Journal of Molecular Biology, Vol. 381, Issue 1
  • DOI: 10.1016/j.jmb.2008.05.062

Ultra-high Resolution Crystal Structure of HIV-1 Protease Mutant Reveals Two Binding Sites for Clinical Inhibitor TMC114
journal, October 2006

  • Kovalevsky, Andrey Y.; Liu, Fengling; Leshchenko, Sofiya
  • Journal of Molecular Biology, Vol. 363, Issue 1
  • DOI: 10.1016/j.jmb.2006.08.007

Sparse Representation for HIV-1 Protease Drug Resistance Prediction
conference, May 2013

  • Yu, Xiaxia; Weber, Irene; Harrison, Robert
  • Proceedings of the 2013 SIAM International Conference on Data Mining
  • DOI: 10.1137/1.9781611972832.38

The structural biology of HIV assembly
journal, April 2008

  • Ganser-Pornillos, Barbie K.; Yeager, Mark; Sundquist, Wesley I.
  • Current Opinion in Structural Biology, Vol. 18, Issue 2
  • DOI: 10.1016/j.sbi.2008.02.001

Conformation of Inhibitor-Free HIV-1 Protease Derived from NMR Spectroscopy in a Weakly Oriented Solution
journal, December 2014


Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
journal, April 2009


Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights
journal, February 2015

  • Chetty, Sarentha; Bhakat, Soumendranath; Martin, Alberto J. M.
  • Journal of Biomolecular Structure and Dynamics, Vol. 34, Issue 1
  • DOI: 10.1080/07391102.2015.1018326

Conformational flexibility in the flap domains of ligand-free HIV protease
journal, July 2007

  • Heaslet, Holly; Rosenfeld, Robin; Giffin, Mike
  • Acta Crystallographica Section D Biological Crystallography, Vol. 63, Issue 8
  • DOI: 10.1107/S0907444907029125

Interaction of I50V Mutant and I50L/A71V Double Mutant HIV-Protease with Inhibitor TMC114 (Darunavir): Molecular Dynamics Simulation and Binding Free Energy Studies
journal, February 2012

  • Meher, Biswa Ranjan; Wang, Yixuan
  • The Journal of Physical Chemistry B, Vol. 116, Issue 6
  • DOI: 10.1021/jp2074804

Extreme Multidrug Resistant HIV-1 Protease with 20 Mutations Is Resistant to Novel Protease Inhibitors with P1′-Pyrrolidinone or P2-Tris-tetrahydrofuran
journal, May 2013

  • Agniswamy, Johnson; Shen, Chen-Hsiang; Wang, Yuan-Fang
  • Journal of Medicinal Chemistry, Vol. 56, Issue 10
  • DOI: 10.1021/jm400231v

[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997


Inhibition of autoprocessing of natural variants and multidrug resistant mutant precursors of HIV-1 protease by clinical inhibitors
journal, May 2011

  • Louis, J. M.; Aniana, A.; Weber, I. T.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 22
  • DOI: 10.1073/pnas.1102278108

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
journal, October 2011

  • May, M.; Gompels, M.; Delpech, V.
  • BMJ, Vol. 343, Issue oct11 2
  • DOI: 10.1136/bmj.d6016

A Comparative Molecular Dynamics, MM–PBSA and Thermodynamic Integration Study of Saquinavir Complexes with Wild-Type HIV-1 PR and L10I, G48V, L63P, A71V, G73S, V82A and I84V Single Mutants
journal, February 2013

  • Tzoupis, Haralambos; Leonis, Georgios; Mavromoustakos, Thomas
  • Journal of Chemical Theory and Computation, Vol. 9, Issue 3
  • DOI: 10.1021/ct301063k

Evolution under Drug Pressure Remodels the Folding Free-Energy Landscape of Mature HIV-1 Protease
journal, July 2016


Works referencing / citing this record:

Exploring the drug resistance mechanism of active site, non-active site mutations and their cooperative effects in CRF01_AE HIV-1 protease: molecular dynamics simulations and free energy calculations
journal, January 2019

  • C. S., Vasavi; Tamizhselvi, Ramasamy; Munusami, Punnagai
  • Journal of Biomolecular Structure and Dynamics, Vol. 37, Issue 10
  • DOI: 10.1080/07391102.2018.1492459

Analysis of drug resistance in HIV protease
journal, October 2018

  • Pawar, Shrikant D.; Freas, Christopher; Weber, Irene T.
  • BMC Bioinformatics, Vol. 19, Issue S11
  • DOI: 10.1186/s12859-018-2331-y

An in silico pharmacological approach toward the discovery of potent inhibitors to combat drug resistance HIV‐1 protease variants
journal, December 2018

  • Nayak, Chirasmita; Chandra, Ishwar; Singh, Sanjeev Kumar
  • Journal of Cellular Biochemistry, Vol. 120, Issue 6
  • DOI: 10.1002/jcb.28181

Exploring the flap dynamics of the South African HIV subtype C protease in presence of FDA-approved inhibitors: MD study
journal, September 2018

  • Maphumulo, Siyabonga I.; Halder, Amit K.; Govender, Thavendran
  • Chemical Biology & Drug Design, Vol. 92, Issue 5
  • DOI: 10.1111/cbdd.13364

Protein engineering: the potential of remote mutations
journal, March 2019

  • Wilding, Matthew; Hong, Nansook; Spence, Matthew
  • Biochemical Society Transactions, Vol. 47, Issue 2
  • DOI: 10.1042/bst20180614

Analysis of drug resistance in HIV protease
journal, October 2018

  • Pawar, Shrikant D.; Freas, Christopher; Weber, Irene T.
  • BMC Bioinformatics, Vol. 19, Issue S11
  • DOI: 10.1186/s12859-018-2331-y

Highly Drug-Resistant HIV-1 Protease Mutant PRS17 Shows Enhanced Binding to Substrate Analogues
journal, May 2019


Highly drug‐resistant HIV‐1 protease reveals decreased intra‐subunit interactions due to clusters of mutations
journal, January 2020

  • Kneller, Daniel W.; Agniswamy, Johnson; Harrison, Robert W.
  • The FEBS Journal, Vol. 287, Issue 15
  • DOI: 10.1111/febs.15207